Oxidative stress, diseases and antioxidant treatment;Estrés oxidativo, enfermedades y tratamientos antioxidantes

Anales de Medicina Interna

Volumn 18, Issue 6, 2001, Pages 326-335

  Elejalde Guerra, J I ^a  

^a NONE   (Spain)

Author keywords

Antioxidant; Free radical; Oxidation; Oxidative stress; Redox

Indexed keywords

FREE RADICAL;

CELL ENERGY; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REDUCTION; REVIEW;

AGED; AGING; ANTIOXIDANTS; ARTERIOSCLEROSIS; ASCORBIC ACID; BETA CAROTENE; CATARACT; DIABETES MELLITUS; DIET; HUMANS; HYPERTENSION; KIDNEY FAILURE, ACUTE; LIVER DISEASES; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRIMARY PREVENTION; RISK FACTORS; SELENIUM; VITAMIN E;

EID: 0034913206     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (176)

1. Reacciones químicas
2. Introducción a la bioquímica y citotoxicidad del desequilibrio oxidativo. II) alteraciones oxidativas en las macromoléculas biológicas
3. Introducción a la bioquímica y citotoxicidad del desequilibbio oxidativo. I) especies activas del oxígeno
4. Radicales libres, formación y daño celular. El sistema antioxidante como protector frente a los radicales libres
5. Antioxidantes, radicales libres y salud. Un enfoque químico-orgánico-físico
6. Free radical mediated tissue damage
7. Free radical and lipid peroxidation
8. Fee radicals, lipids and protein degradation
9. Importancia de los antioxidantee en la alimentación humana
10. The reduction of inert free radicals with ascorbic acid. The reaction with perclorotriphenylmethylradical
11. Intracellular proteolytic systems may function as secundary antioxidant defences: As hypothesis
12. Introducción a la bioquímica y citotoxicidad del desequilibrio oxidativo. III) sistemas de defensa y reparación
13. Non invasive measures of oxidative stress status in humans
14. Oxidative stress status: OSS, BOSS and "Wild Bill" Donovan
15. Oxidative stress status - The second set
16. Oxidative stress status - The third set
17. Forum on oxidative stress status (OSS) and its measurement
18. Affinity biosensors based on preconcentration/voltammetric analysis. Detection of phenothiazine drugs at Langmuir-Blodgett films of tyrosine hydroxylase
19. The reduction potential of cytocrhome b5 is modulated by its exposed hene edge
20. The use of cyclic voltammetry for the evaluation of antioxidant capacity
21. Quantification of the overall reactive oxygen species scavenging capacity of biological fluids and tissues
22. Magnetic resonance spectroscopic measurement of cellular thiol reduction-oxidation state
23. Oxygen in mammalian tissue: Methods of measurement and affinities of various reactions
24. Primary sequence, oxidation-reduction podentials and tertiary structure prediction of Desulfovibrio desulfuricans ATCC 27774 flavodoxin
25. The antipsoriasic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes
26. Potenciometric and electron nuclear double resonance properties of the two spin forms of the 4-Fe-4S + cluster in the novel ferredoxin from the hyperthermophilic archaebacterium Pyrococcus furiosus
27. Oxidation-reduction potentials of flavin and Mo-pterin centers in assimilatory nitrate reductase: Variation with pH
28. Measurement of oxidation-reduction midpoint potentials by room temperature electron paramagnetic resonance potenciometry
29. Combination of potentiometry and resonance Raman spectroscopy for the analysis of a redox protein
30. Resonance Raman and optical spectroscopic monitoring of heme a redox states cytochrome c oxidase during potenciometric titrations
31. Combination of potentiometry and resonance Raman spectroscopy for the analysis of a redox protein
32. Oxidation-reduction potentials and ionization states of extracelular peroxidases from the lignin-degrading fungus Phanerochaete chysosporium
33. The measurements of oxygen-derived free radicals and related substances in medicine
34. Le stress oxydant: Intérêt de sa mise en évidence en biologie médicale et probleme posés par le choix d'un marqueur
35. Efectos gasométricos y hemodinámicos de la inhalación de óxido nítrico en pacientes con síndrome de distres respiratorio agudo
36. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy
37. Renal corticomedullary metabolite gradients during graded arterial occlusion: A localized 31P magnetic resonance spectroscopy study
38. The measurements of oxygen-derived free radicals and related substances in medicine
39. Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging
40. Noninvasive study of radiation-induced oxidative damage using in vivo electron spin resonance
41. ¿Participan los radicales libres en los procesos de peroxidación lipídica?
42. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels
43. The cytotoxic effect of paraquat to isolated renal proximal tubular segments from rabbits
44. The hepatotoxicity of rhein involves impairement of mitochondrial functions
45. Antioxidant effects of a supplemented very low protein diet in chronic renal failure
46. Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis
47. Immunohistochimical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implications for glycoxidative stress in the pathogenesis of diabetic nephropathy
48. Indices of oxidative stress in urina of patients undergoing coronary artery bypass grafting
49. Role of lipid peroxidation, trace elements and antioxidants enzymes in chronic renal disease patients
50. Lipid peroxidation assessment of free radical production following release of obstructive uropathy
51. Oxidative stress and enzyme activity in ambulatory renal patients undergoing continuous peritoneal dialysis
52. Heart failure
53. Carvedilol protects againts glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol
54. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis
55. Reduced free radical scavengers and chronic renal failure
56. Influence of dialysis on plasma lipid peroxidation products and antioxidants levels
57. 8-Isoprostaglandin F2a, a product of lipid peroxidation increases portal pressure in normal and cirrhotic rats
58. Measurement of F2-isoprostanes as an index of oxidative stress in vivo
59. Antioxidants status of eldrely chronic renal patients treated by continuos ambulatory peritoneal dialysis
60. Avanced oxidation protein products as a novel marker of oxidative stress in uremia
61. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate
62. 4-Hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: Protein modification and redox alteration
63. Simple methods of quantifying oxidation products and antioxidants potential of low density lipoproteins
64. Measurement of oxidative stress status in humans
65. Methods for measuring ethane and pentane in expired air from rats and humans
66. Breath alkanes as a marker of oxidative stress in different clinical conditions
67. Detection of oxidative DNA damage in human sperm and its association with sperm function and male infertility
68. Glomerular atherosclerosis
69. Biomarkers of oxidative stress study: Are plasma antioxidants markers of CC14 poisoning?
70. Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a posible marker of oxidative stress
71. Ratiometric methodology fod NAD(P)H measurement in the perfused rat heart using surface fluorescence
72. Scanning microfluorimetric measurements of redox status in the rat dento-alveolar tissues
73. Sulfur K-edge x-ray absortion spectroscopy: A spectroscopic tool to examinate the redox state of S-containing metabolites in vivo
74. Rapid automated determination of lipid hydroxiperoxide concentration and total antioxidant status of serum samples from patients infected with HIV: Elevaded lipid hydroperoxide concentrations and depleted antioxidant capacity of serum samples
75. Diurnal fluctuations of arterial ketone body ratio in normal subjects and patients with liver dysfunction
76. Impaired polymorphonuclear leucocyte function in patients undergoing hepatectomy: Adenylate energy charge and superoxide anion production in relation to hepatic mitochondrial redox state
77. Fiber optic surface fluorometry-reflectometry technique in the renal physiology of rats
78. Calcium-dependent cell death. Role of the endonuclease, protein kinase C, and chromatin conformation
79. Oxidative stress and citoskeletal alterations
80. Oxidants, antioxidants and degenerative diseases of ageing
81. Free radical involvement in ageing. Pathophysiology and therapeutic implications
82. Metal-catalyzed oxidation of protein. Physiological Consequences
83. Decreased enzymic protection and increased sensitivity to oxidative damage in erythrocytes as a function of cell and donor aging
84. Regulation of intracelular protein turnover. Covalent modification as a mechanism of marking proteins for degradation
85. A binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoproteins producing massive cholesterol deposition
86. Fenómenos oxidativos en la fisiopatología vascular
87. Role of oxidized low density lipoprotein in atherogenesis
88. Forum: Role of oxidation in atherosclerosis. Oxidation and atheroesclerosisi
89. Antioxidant and atheroesclerotic heart disease
90. Differential ability of cells to promote oxidation of low density lipoproteins in vitro
91. Prooxidant states and tumor promotion
92. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
93. Papel del estrés oxidativo en la expresión de genes: Isquemia miocárdica, cerebral, cáncer y otras enfermedades
94. Antioxidant enzyme levels in cancer
95. Epidemiological evidence regarding vitamin C and cancer
96. Cataract relationships between nutrition and oxidation
97. Hridroxyl production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellirus and ageing
98. Emerging therapies for acute renal failure
99. Redox regulation of renal DNA synthesis, transforming growth factor-beta 1 and collagen gene expresion
100. Increased susceptibility of LDL to in vitro oxidation in patients on maintenence hemodialysis: Effects of fish oil and vitamin E administration
101. Lipid abnormalities of erythrocyte in hemodialysis patients with chronic renal failure
102. Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograf transplantation and the effect on early graft function
103. Low-density lipoprotein oxidation is increased in kidney transplant recipients
104. Gentamicin induced kidney damage and lipid peroxidation in rats
105. Lipid peroxidation accompanies cyclosporine nefhrotoxicity: Effects of vitamin E
106. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: A possible explanation for increased cardiovascular risk in these patients
107. Cardiología, estrés oxidativo, nutrición y biología molecular. Consideraciones generales
108. Glycation, oxidative stress, and scavenger activity: Glucose metabolism and radical scavenger dysfunction in endothelial cells
109. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients
110. Papel de la prooxidación y la antioxidación en la etiología de la hipertensión arterial
111. Lipid peroxidation in patients with hypertension and renal hypertension against a background of diabetes mellitus
112. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective
113. 8-Isoprostaglandin F2a, a product of lipid peroxidation increases portal pressure in normal and cirrhotic rats
114. Alcohol and antioxidant systems
115. Hypoxia and reoxygenation induced injury of renal epithelial cells: Effect of free radical scavengers
116. Selective antioxidant enzymes during ischemia/reperfusion in myocardial infarction
117. Effects of reactive oxygen species on myelin membrane proteins
118. Oncogene activation in rheumatoid synovium
119. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions
120. Estrés oxidativo y patología infecciosa
121. Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis
122. Antioxidant vitamins and coronary heard disease
123. Antioxidants and the influence of free radical damage to proteins on proteolisys in and around mammalian cells
124. Prediagnostic serum selenium and risk of cancer
125. Role of oxidative stress in transition of hypertrophy to heart failure
126. Effect of coenzyme Q10 theraphy in patients with congestive heart failure: A long-term multicenter randomized study
127. Antioxidant effect of carvedilol and metoprolol in congestive heart failure
128. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical
129. Vitamin E consumption and the risk of coronary heart disease in men
130. Vitamin E consumption and the risk of coronary heart disease in women
131. Vitamin C intake and mortality among a sample of the United States population
132. Beta carotene therapy for chronic stabel angina
133. Protective effects of carvedilol in the myocardium
134. Comparative study of the effect of 21-aminoesteroid and a-tocofer on model of acute oxidative renal injury
135. Oxidative stress status: An introduction
136. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
137. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study
138. Probucol and multivitamins in the prevention of restenosis after coronary angioplaty
139. Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine
140. Intake of specific carotenoids and risk of lung cancer in 2 prospectives US cohorts
141. Tumor invasion is inhibited by phosphorylated ascorbate via enrichment of intracellular vitamin C and decreasing of oxidative stress
142. Use of antioxidants to treat pain in chronic pancreatitis
143. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology
144. Niveles plasmáticos de vitamina A y E y riesgo de infarto agudo de miocardio
145. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
146. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly
147. Vitamin E supplementation and cardiovascular events in high-risk patients
148. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
149. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancer in male smokers
150. Randomised trial of alphatocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
151. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
152. Role of antioxidant vitamins in prevention of cardiovascular disease. Meta-analysis seems to exclude benefit of vitamin C supplementation
153. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC Study
154. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISS-Prevenzione trial
155. Vitamin E and heart disease: Basic science to clinical intervention trials
156. ¿Se debe recomendar antioxidantes para la prevención cardiovascular?
157. Beta carotene: From biochemistry to clinical trials
158. Antioxidant vitamins, cancer and cardiovascular disease
159. Vitamin E for Alzheimer's disease (Cochrane Review)
160. Update on vitamin supplements for the prevention of coronary disease and stroke
161. Antioxidant therapy in neurologic disease
162. Observation on effect of sodium selenite in the prevention of Keshan disease
163. Capacidad antioxidante de la melatonina: Su papel defensivo contra afecciones relacionadas con la edad
164. Actividad física y arteriosclerosis. Efectos de la actividad física sobre la oxidación lipídica, la hemostasia y la función endotelial
165. Excelencias de la dieta mediterranea. Dieta roma-tokio vs american fast-fat food
166. Mediterranean dietary pattern in a randomized trial: Prolonged survival and possible reduced cancer rate
167. Cretan Mediterranean diet for prevention of coronary heart disease
168. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final Report on The Lyon diet Heart Study
169. Aceite de oliva e inhibición de la oxidación de las lipoproteínas de baja densidad. Importancia de los compuestos fenólicos
170. La dieta mediterranea mejora la resistencia a la oxidación de las lipoproteinas de baja densidad (LDL)
171. El vino a dosis moderadas: Salud o enferemedad